Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04077320
Other study ID # BSCAN1920
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date December 20, 2024

Study information

Verified date December 2023
Source Western University, Canada
Contact Lindsay S Nagamatsu, PhD
Phone 519-661-2111
Email lindsay.nagamatsu@uwo.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Confidence in one's ability to accomplish a task, more formally known as self-efficacy, is an important psychological variable that can influence how the investigators perform on various tasks. Previous studies have shown that self-efficacy is a modifiable trait that can be improved and bolstered with training and practice. More importantly for this study, memory self-efficacy has been shown to be modifiable for older adults, consequently improving their performance on memory tasks. While there is evidence to support the importance of memory self-efficacy for successful memory performance in older adults, the underlying neurological changes that accompany these performance changes have not been explored. The goal of this study is to examine the changes in brain activity before and after a memory self-efficacy training program to better understand the mechanisms of both memory and self-efficacy.


Recruitment information / eligibility

Status Recruiting
Enrollment 28
Est. completion date December 20, 2024
Est. primary completion date December 20, 2024
Accepts healthy volunteers No
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria: 1. Subjective memory complaints within past 5 years 2. Objective memory impairment below age norms on standardized cognitive testing 3. Score below 25 on Montreal Cognitive Assessment 4. Scores 1.5 standard deviations below age norms on memory testing 5. Unimpaired performance in Activities of Daily Living 6. Intact general cognition 7. Fluently read, write and speak English 8. Right handed Exclusion Criteria: 1. Co-morbidity that would impact cognition (depression, anxiety, stroke) 2. Prior diagnosis of dementia of any type 3. Use of prescription or recreational drug use that would impact cognition (excluding hormone replacement therapy) 4. Uncorrected visual or auditory deficits/impairments 5. Current participation in alternate study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Memory Self-Efficacy Training
The intervention will consist of a six-week cognitive behavioral intervention integrating the four pillars of self-efficacy, Mastery, Social Modeling, Coaching, and Physiological Responses (West et al. 2008). Each week will comprise of a 1.5 hour session which focuses on an educational component, discussions and active learning practice activities to apply lesson material. Additionally, participants will be given take home exercises to practice outside a classroom setting. The sessions will be conducted in small groups of 4-6 people.
General Education
The active control intervention will be a general education class consisting of real world knowledge and factual information on various topics unrelated to memory. This intervention will follow the same format as the memory self-efficacy training arm. One 1.5 hours session every week for 6 weeks, in small groups.

Locations

Country Name City State
Canada Community London Ontario

Sponsors (2)

Lead Sponsor Collaborator
Western University, Canada Western BrainsCAN

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Memory self-efficacy: Multifactorial Memory Questionnaire (MMQ) Multifactorial Memory Questionnaire (MMQ), 5-point scale Likert questions (min 0, max 4) evaluating subjective memory satisfaction, ability and strategy use.
Satisfaction: 18 questions. Raw scores can be converted to T Scores using the normative data presented in MMQ administration and scoring manual. Converted T-Scores can range from 15 to 85. T-scores between 40-60 are considered normal relative to the population. While those below 40 are considered low scores and those above 60 high scores.
Ability: 20 questions. Raw scores can be converted to T Scores using the normative data presented in MMQ administration and scoring manual. Interpretation of T-scores same as above sub-scale.
Strategy: 19 questions. Raw scores can be converted to T Scores using the normative data presented in MMQ administration and scoring manual. Interpretation of T-scores same as above sub-scale.
Each of the three MMQ scales is scored and interpreted separately.
Pre and Post intervention - 6 weeks
Other Memory self-efficacy: Memory Self-efficacy Questionnaire (MSEQ) subjective scale Memory self efficacy will be evaluated and compared between groups to evaluate the efficacy of each intervention arm. As there is no one measure that is the gold standard for memory self-efficacy two validated measures will be used for comparison.
Measure by 2) Memory Self-efficacy Questionnaire (MSEQ) subjective scale of participant's confidence in completing various memory related tasks.
Each task is scored by percent confidence of successfully completing the task (0 - 100%) Total memory self-efficacy is calculated by summing each task and taking the average. Values closer to 0% represent a worse overall memory self-efficacy, while values closer to 100% represent better memory self-efficacy.
Pre and Post intervention - 6 weeks
Primary Neurological bio-markers: Regional activation Using fMRI identify changes in activation patterns or signal change when performing an associative memory task Pre and Post intervention - 6 weeks
Primary Neurological bio-markers: Default mode network Using fMRI during a resting state observe changes in default mode network activation Pre and Post intervention - 6 weeks
Secondary Story Recall - Trained memory performance task Observe the changes in memory performance using measures that were specifically practiced in the training intervention. Recall of a short story to estimate episodic memory capacity. Pre and Post intervention - 6 weeks
Secondary List Recall - Trained memory performance tasks Observe the changes in memory performance using measures that were specifically practiced in the training intervention. Recall of a visually presented list of unrelated words to estimate episodic memory capacity and working memory. Pre and Post intervention - 6 weeks
Secondary Face-Name Pairs - Trained memory performance tasks Observe the changes in memory performance using measures that were specifically practiced in the training intervention. Recall of a face-name pairs to evaluate associative memory. Pre and Post intervention - 6 weeks
Secondary RAVLT - Untrained memory performance tasks Observe the changes in memory performance using measures that were not specifically practiced in the training intervention.
Participants are asked to recall a list of verbally presented words immediately after presentation and after a delay. Used to evaluate sort term verbal memory and long term memory
Pre and Post intervention - 6 weeks
Secondary Visual Spatial Learning Task - Untrained memory performance tasks Observe the changes in memory performance using measures that were not specifically practiced in the training intervention.
Subjects are given time to learn the location and design of shapes on a 6 x 4 matrix. Subjects are required to correctly select the 7 correct shapes from a selection of 15 and place them on the grid. Used to measure visual spatial memory
Pre and Post intervention - 6 weeks
Secondary Digit Span Task - Untrained memory performance tasks Observe the changes in memory performance using measures that were not specifically practiced in the training intervention.
A series of numbers are verbally presented, increasing in length for the participant to repeat back. Measures working memory
Pre and Post intervention - 6 weeks
Secondary Face-Scene Pairs - Untrained memory performance tasks Observe the changes in memory performance using measures that were not specifically practiced in the training intervention.
An alternative form of evaluating associative memory ability. Participants will be given face and scene pairs to remember.
Pre and Post intervention - 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A